Clinically defined chemotherapyassociated bowel syndrome predicts severe complications

Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients by Maria J. G. T. Vehreschild, Arne M. K. Meißner, Oliver Andreas Cornely, Georg Maschmeyer, Silke Neumann, Marie von Lilienfeld-Toal, Meinholf Karthaus, Mohammed Wattad, Peter Staib, Martin Hellmich, Hildegard Christ, and Jörg Janne Vehreschild haematol Volume 96(12): 1855 -1860 December 6, 2011 © 2011 by Ferrata Storti Foundation

Flow chart of study progress. Maria J. G. T. Vehreschild et al. Haematologica 2011; 96: 1855 -1860 © 2011 by Ferrata Storti Foundation

Indications for chemotherapy and cytostatic agents administered during first episodes of neutropenia. Maria J. G. T. Vehreschild et al. Haematologica 2011; 96: 1855 -1860 © 2011 by Ferrata Storti Foundation

Absolute increase in the risk of transfer to intensive care in patients with chemotherapyassociated bowel syndrome (P<0. 0001). Maria J. G. T. Vehreschild et al. Haematologica 2011; 96: 1855 -1860 © 2011 by Ferrata Storti Foundation

Absolute increase in mortality in patients with chemotherapy-associated bowel syndrome (P<0. 0043). Maria J. G. T. Vehreschild et al. Haematologica 2011; 96: 1855 -1860 © 2011 by Ferrata Storti Foundation

Results of backward-stepwise binary logistic regression analysis assessing risk factors for “transfer to intensive care” and “death”. Maria J. G. T. Vehreschild et al. Haematologica 2011; 96: 1855 -1860 © 2011 by Ferrata Storti Foundation